Home›Stock Screener›Aakaar Medical Technologies›Financial Statements

Aakaar Medical Technologies Complete Financial Statements

6 Years of Data
2025 - 2020

In FYNone, Aakaar Medical Technologies (AAKAAR) reported revenue ₹0 Cr, net profit ₹0 Cr and EPS ₹0.00, with a net profit margin of 9.7% and ROE of 26.1%. Full financial statements from FY2020 to FY2025 (6 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Explore Aakaar Medical Technologies intrinsic price to estimate fundamental worth using multiple valuation models.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 9.68% 2025 data
EBITDA Margin 16.13% 2025 data
Operating Margin 16.00% 2025 data
Return on Assets 11.11% 2025 data
Return on Equity 26.09% 2025 data

Balance Sheet Ratios

Current Ratio 52.00 2025 data
Equity Ratio 42.59% 2025 data
Asset Turnover 1.15 2025 data

AAKAAR Revenue, Net Profit & EBITDA — Year-on-Year Growth

AAKAAR YoY (March 2025 vs Period) — revenue -100.0%, net profit -100.0%, EBITDA -100.0%, expenses -100.0%. For live price, earnings ratios and company overview, see AAKAAR share price.

Revenue Growth
-100.0%
Year-over-Year
Net Profit Growth
-100.0%
Year-over-Year
EBITDA Growth
-100.0%
Year-over-Year
Expense Growth
-100.0%
Year-over-Year
Assets Growth
+58.8%
Year-over-Year
Equity Growth
+76.9%
Year-over-Year
Operating Cash Flow Growth
+37.5%
Year-over-Year
Financing Cash Flow Growth
+37.5%
Year-over-Year

AAKAAR Income Statement — Revenue, EBITDA & Net Profit

Aakaar Medical Technologies revenue ₹0 Cr, EBITDA ₹0 Cr, net profit ₹0 Cr, EPS ₹0.00 (None) — net profit margin 9.7%. Review AAKAAR P/E ratio to evaluate earnings-based valuation against sector peers.

Periods ₹ Crores
Particulars None March 2025 March 2024 March 2023 March 2022 March 2021 March 2020
Revenue 0 62 46 33 20 13 23
Expenses 0 52 41 29 17 12 20
EBITDA 0 10 5 4 2 1 3
Operating Profit Margin % 0.00% 16.00% 11.00% 11.00% 12.00% 7.00% 13.00%
Depreciation 0 0 0 0 0 0 0
Interest 0 2 1 0 0 0 1
Profit Before Tax 0 8 4 3 2 1 3
Tax 0 2 1 1 1 0 1
Net Profit 0 6 3 2 2 1 2
Earnings Per Share (₹) 0.00 6.13 3.15 2.37 1.78 54.44 182.79

AAKAAR Balance Sheet — Assets, Liabilities & Shareholders' Equity

AAKAAR total assets ₹54 Cr, total equity ₹23 Cr, total liabilities ₹ Cr (2025) — ROE 26.1%.

Years Annual Data ₹ Crores
Particulars 2025 2024 2023 2022 2021 2020
ASSETS
Total Assets 54 34 23 18 14 16
Current Assets 52 33 22 17 14 16
Fixed Assets 0 0 0 0 0 0
Capital Work in Progress 0 0 0 0 0 0
Investments 0 0 0 0 0 0
Other Assets 54 34 23 18 14 16
LIABILITIES
Total Liabilities
Current Liabilities 1 1 1 1 4 6
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 23 13 10 8 7 7
Share Capital 10 1 1 1 0 0
Reserves & Surplus 13 12 9 7 7 7

AAKAAR Cash Flow Statement — Operating, Investing & Financing

Aakaar Medical Technologies operating cash flow ₹-5 Cr, investing ₹0 Cr, financing ₹11 Cr, net cash flow ₹5 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020
Operating Activities -5 -8 -3 1 4 0
Investing Activities 0 0 0 0 0 0
Financing Activities 11 8 1 -1 -2 0
Net Cash Flow 5 0 -2 -1 3 0